Example: Heart Attack

Search clinical trials for: 68Ga-FAPI-RGD

Total 2493 results

NCT07319897

Not yet recruiting

A Prospective, Multicenter, Diagnostic Study Evaluating 68Ga-BCMA PET/CT for Targeting BCMA Expression in Multiple Myeloma.

Multiple Myeloma | Multiple Myeloma and Plasma Cell Neoplasm | Multiple Myeloma and Malignant Plasma Cell Neoplasms
NCT07172503

Not yet recruiting

Clinical Application of PET Imaging Targeting GPA33 in Malignant Tumors

Colorectal Cancer | Pancreatic Cancer | Gastric Cancer (GC)
NCT07144748

Recruiting

68Ga-NYM096 PET/CT in Various Kinds of Cancer (NYCRVT)

Cancer
NCT06871176

Recruiting

PET/MR Scan With [68Ga]Ga-PentixaFor (CXCR4) vs Standard of Care (SOC) for Initial Staging and Follow up in Multiple Myeloma (MM)

Multiple Myeloma
NCT06725940

Recruiting

GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast Cancer (GzmB-PET4BC)

Breast Cancer Invasive
NCT05490264

Recruiting

[68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors

Solid Tumor | Positron-Emission Tomography(PET)
NCT03736564

Completed

Ga-DOTATATE PET for Phosphaturic Mesenchymal Tumors in Patients With Tumor Induced Osteomalacia

Osteomalacia
NCT03873870

Completed

68Ga-DOTATATE PET for Management of Neuroendocrine Tumors

Neuroendocrine Tumors
NCT02317393

Completed

Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy (TERMATEP)

Metastasis | Non-seminomatous Germ Cell Tumors
NCT01582516

Completed

Safety Study of Replication-competent Adenovirus (Delta-24-rgd) in Patients With Recurrent Glioblastoma

Brain Tumor | Recurring Glioblastoma
NCT00743353

Completed

Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5 (K5)

Melanoma | Sarcoma | Breast Cancer | Lung Cancer | High Grade Gliomas
NCT04888481

Recruiting

68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors

Neuroendocrine Tumors
NCT05955677

Recruiting

Head-to-head Comparison of [68Ga]Ga-PSMA-D5 With [68Ga]Ga-PSMA-11 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

Prostate Cancer | PET/CT
NCT07117214

Recruiting

A Phase I Study of [68Ga]Ga-DWJ155 in Patients With Breast and Lung Cancers

Breast Neoplasms | Carcinoma, Non-Small-Cell Lung
NCT06844110

Recruiting

Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Malignant Tumor

Tumor Immunity
NCT06411678

Recruiting

Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer

Breast Cancer
NCT06049368

Not yet recruiting

68Ga-P16-093 PET/CT Imaging in the Salivary Gland

Primary Sjögren Syndrome
NCT05569434

Recruiting

68Ga-P16-093 PET/CT Imaging in Glioma Patients

Glioma
NCT07597759

Completed

Phase IIT Trial of SNA009

Colorectal Cancer | GPA33
NCT04561492

Active, not recruiting

Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma (PentiMyelo)

Multiple Myeloma
NCT06463782

Completed

Clinical Study of 68Ga-LNC1007 Injection PET/CT

Healthy Volunteers | Cancer Patients
NCT06389695

Completed

Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM032 in Patients

Prostate Cancer
NCT03073395

Completed

Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal Cancer

Prostate Cancer | Renal Cancer
NCT05126927

Completed

A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors

Solid Tumor
NCT02490891

Completed

Study of the Angiogenesis by PET/CT in Patients With Lymphoma (RGDLymphome)

Lymphoma
NCT05410821

Completed

Evaluation of 177Lu-DOTA-EB-FAPI in Patients With Metastatic Radioactive Iodine Refractory Thyroid Cancer

Refractory Thyroid Gland Carcinoma | Refractory Thyroid Gland Papillary Carcinoma | Refractory Thyroid Gland Follicular Carcinoma | Refractory Thyroid Gland Hurthle Cell Carcinoma
NCT03362359

Completed

Ga-68-PSMA-11 in High-risk Prostate Cancer

Prostate Cancer | Prostate Cancer Metastatic | High-risk Prostate Cancer | Lymphnode Metastasis
NCT06107608

Recruiting

Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors (LIFE)

Non Small Cell Lung Cancer
NCT07423013

Recruiting

Evaluating the Efficacy and Safety of Teprotumumab N01 in Patients With Thyroid Eye Disease.

Thyroid Eye Disease
NCT06182644

Recruiting

Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant Tumors (FAPI)

Renal Cell Carcinoma | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Mucinous Adenocarcinoma | Signet Ring Cell Carcinoma
NCT05356923

Completed

PROFILE-MI - The FAPI Fibrosis Study

Myocardial Infarction | Myocardial Fibrosis
NCT01832584

Completed

Effect of Red Grape Cells (RGC) Powder Consumption on Measures of Aerobic Fitness and Mood

Healthy
NCT07177482

Recruiting

ImmunoPET Targeting Trophoblast Cell-surface Antigen 2 (Trop-2) in Craniopharyngioma Patients

Craniopharyngioma
NCT07151898

Recruiting

PET/CT for Trop2 ADC Response Evaluation NSCLC

NSCLC | PET/CT | Trop2
NCT07046689

Recruiting

PET/CT for Trop2 ADC Response Evaluation Cancers

Breast Cancer | PET/CT | Trop2
NCT07020806

Recruiting

[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)

Metastatic Lobular Breast Carcinoma
NCT06949215

Recruiting

68Ga-NYM096 PET/ CT for the Detection of ccRCC in Presurgical Patients With Complex Cystic Renal Leision (NYCRCCL)

Complex Renal Cyst | ccRCC
NCT06646783

Not yet recruiting

Phase IIT Trial of SNA014

Adenocarcinoma of GE Junction | Adenocarcinoma of the Stomach | Pancreatic Cancer Stage
NCT06612580

Recruiting

68Ga-AAZTA-NI-093 PET/CT: First-in-human Study

Prostate Cancer (Adenocarcinoma)
NCT06454955

Recruiting

Study on B7-H3 Targeted Affibody Radioligand Probes for PET Imaging of Solid Tumors

B7H3 | CD276 Affibody | PET/CT Imaing
NCT07023068

Enrolling by invitation

⁶⁸Ga-DPA in the Lung Cancer Diagnosis

Lung Cancers
NCT05784597

Completed

A Study to Evaluate the Safety and Dosimetry of 68Ga-labelled OncoFAP Derivatives in Solid Tumors (FAPrimo)

Breast Cancer | Colorectal Cancer | Pancreas Adenocarcinoma | Oesophageal Cancer
NCT04422457

Completed

Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients

Solid Tumor
NCT05536960

Completed

Dotatate to Locate Coronary Plaques at High-risk of Myocardial Infarction (DOLPHIN)

Atheroscleroses, Coronary
NCT07656337

Not yet recruiting

Effects of Direct Artery Injection on Prostate Cancer Drug Delivery and Tumor Uptake: Imaging-Based Prediction of Treatment Effectiveness (IAPSMA)

Prostate Cancer | Prostate Adenocarcinoma
NCT07577206

Recruiting

Single Microdose Trial- CXCR4 PET Tracer - Pharmacokinetics and Pharmacodynamics of [68Ga]Ga-R54, a Radiopharmaceutical Directed Toward CXCR4 in Patients With Advanced Solid Neoplasia.

Multiple Myeloma | Advanced Solid Tumor
NCT06201741

Recruiting

A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled ZT-111 in Patients With Metastatic Prostate Cancer

Prostate Specific Membrane Antigen Positive Metastatic Prostate Cancer
NCT05982626

Recruiting

Study of 68Ga /131I SGMIB-ZT-199 PET Imaging Targeting HER2-positive in the Diagnosis of Metastatic Breast Cancer

HER2-positive Breast Cancer
NCT05446324

Recruiting

Feasibility of Gallium-68-tilmanocept PET/CT for Sentinel Lymph Node Detection in Endometrial Cancer (SENGA)

Endometrial Cancer
NCT05285696

Completed

Study to Evaluate the Safety and Dosimetry of [68Ga]-NOTA-hGZP (CSB-111) PET Imaging in Healthy Human Volunteers.

Healthy Volunteers

Search clinical trials for: 68Ga-FAPI-RGD

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations